Tripalmitoyl cysteine | CAS#87079-94-5 | synthetic analog

MedKoo Cat#: 597024 | Name: Tripalmitoyl cysteine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tripalmitoyl cysteine is a synthetic analog of N-terminal lipid part of bacterial lipoprotein.

Chemical Structure

Tripalmitoyl cysteine

CAS#87079-94-5

Theoretical Analysis

MedKoo Cat#: 597024

Name: Tripalmitoyl cysteine

CAS#: 87079-94-5

Chemical Formula: C55H105NO7S

Exact Mass: 923.7612

Molecular Weight: 924.50

Elemental Analysis: C, 71.45; H, 11.45; N, 1.52; O, 12.11; S, 3.47

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Tripalmitoyl cysteine; Tripalmitoyl-S-glyceryl cysteine;

IUPAC/Chemical Name

3-(((R)-3-methoxy-3-oxo-2-palmitamidopropyl)thio)propane-1,2-diyl dipalmitate

InChi Key

BKXQBXXALHYQKZ-NPGUAINNSA-N

InChi Code

InChI=1S/C55H105NO7S/c1-5-8-11-14-17-20-23-26-29-32-35-38-41-44-52(57)56-51(55(60)61-4)49-64-48-50(63-54(59)46-43-40-37-34-31-28-25-22-19-16-13-10-7-3)47-62-53(58)45-42-39-36-33-30-27-24-21-18-15-12-9-6-2/h50-51H,5-49H2,1-4H3,(H,56,57)/t50?,51-/m0/s1

SMILES Code

O=C(OC)[C@H](CSCC(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O)NC(CCCCCCCCCCCCCCC)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 924.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Khoo AL, Chai LY, Koenen HJ, Sweep FC, Joosten I, Netea MG, van der Ven AJ. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol. 2011 Apr;164(1):72-9. doi: 10.1111/j.1365-2249.2010.04315.x. Epub 2011 Feb 16. PubMed PMID: 21323660; PubMed Central PMCID: PMC3074219. 2: Udan ML, Ajit D, Crouse NR, Nichols MR. Toll-like receptors 2 and 4 mediate Abeta(1-42) activation of the innate immune response in a human monocytic cell line. J Neurochem. 2008 Jan;104(2):524-33. Epub 2007 Nov 6. PubMed PMID: 17986235. 3: Zaidi AK, Thangam ER, Ali H. Distinct roles of Ca2+ mobilization and G protein usage on regulation of Toll-like receptor function in human and murine mast cells. Immunology. 2006 Nov;119(3):412-20. PubMed PMID: 17067316; PubMed Central PMCID: PMC1819569. 4: Langhans B, Braunschweiger I, Nischalke HD, Nattermann J, Sauerbruch T, Spengler U. Presentation of the HCV-derived lipopeptide LP20-44 by dendritic cells enhances function of in vitro-generated CD4+ T cells via up-regulation of TLR2. Vaccine. 2006 Apr 12;24(16):3066-75. Epub 2006 Feb 10. PubMed PMID: 16504351. 5: Yoder A, Wang X, Ma Y, Philipp MT, Heilbrun M, Weis JH, Kirschning CJ, Wooten RM, Weis JJ. Tripalmitoyl-S-glyceryl-cysteine-dependent OspA vaccination of toll-like receptor 2-deficient mice results in effective protection from Borrelia burgdorferi challenge. Infect Immun. 2003 Jul;71(7):3894-900. PubMed PMID: 12819074; PubMed Central PMCID: PMC161983. 6: Zeng W, Ghosh S, Lau YF, Brown LE, Jackson DC. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. J Immunol. 2002 Nov 1;169(9):4905-12. PubMed PMID: 12391202. 7: Ridgely SL, McGuire TC. Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses. Vaccine. 2002 Mar 15;20(13-14):1809-19. PubMed PMID: 11906769. 8: Langhans B, Braunschweiger I, Schweitzer S, Jung G, Inchauspé G, Sauerbruch T, Spengler U. Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro. Immunology. 2001 Apr;102(4):460-5. PubMed PMID: 11328380; PubMed Central PMCID: PMC1783202. 9: Nardin EH, Calvo-Calle JM, Oliveira GA, Clavijo P, Nussenzweig R, Simon R, Zeng W, Rose K. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. Vaccine. 1998 Apr;16(6):590-600. PubMed PMID: 9569470. 10: Borges E, Wiesmüller KH, Jung G, Walden P. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. J Immunol Methods. 1994 Aug 1;173(2):253-63. PubMed PMID: 7519223. 11: DeOgny L, Pramanik BC, Arndt LL, Jones JD, Rush J, Slaughter CA, Radolf JD, Norgard MV. Solid-phase synthesis of biologically active lipopeptides as analogs for spirochetal lipoproteins. Pept Res. 1994 Mar-Apr;7(2):91-7. PubMed PMID: 8012126. 12: Nardelli B, Tam JP. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide. Immunology. 1993 Jul;79(3):355-61. PubMed PMID: 8104882; PubMed Central PMCID: PMC1421990. 13: Metzger JW, Sawyer WH, Wille B, Biesert L, Bessler WG, Jung G. Interaction of immunologically-active lipopeptides with membranes. Biochim Biophys Acta. 1993 Jun 18;1149(1):29-39. PubMed PMID: 8391319. 14: Bessler WG, Bessler U, Eck G, Scheuer WV, Suhr B. [In vitro methods for testing of plant derived, bacterial and synthetic agents and toxins with the use of leukocyte primary cell cultures and cell lines]. Arzneimittelforschung. 1985;35(8):1209-15. German. PubMed PMID: 2416324. 15: Johnson RB, Köhl S, Wiesmüller K, Jung G, Bessler WG. Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo. Immunobiology. 1983 Jul;165(1):27-35. PubMed PMID: 6350164.